|
|
|
Search for: "Cephalon"
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Venture Capital
[Celator Pharmaceuticals]
|
TARIS Appoints Sarma Duddu as President and CEO
HSMN NewsFeed,
19 Jul 2010:
Biopharmaceuticals, Personnel
[TARIS Biomedical]
|
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
HSMN NewsFeed,
9 Apr 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Cephalon, Mepha]
|
Cephalon Completes Acquisition of Ception Therapeutics
HSMN NewsFeed,
5 Apr 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Cephalon, Ception Therapeutics, CINQUIL, reslizumab, asthma]
|
Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division
HSMN NewsFeed,
8 Feb 2010:
Biopharmaceuticals, Personnel
[Aton Pharma, Orphan Drug]
|
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
HSMN NewsFeed,
1 Feb 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Cephalon, Mepha AG]
|
Ligand Completes Acquisition of Metabasis
HSMN NewsFeed,
28 Jan 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Ligand Pharmaceuticals, Metabasis Therapeutics]
|
Cephalon Announces Executive Leadership Changes
HSMN NewsFeed,
28 Jan 2010:
Biopharmaceuticlas, Personnel
[Cephalon]
|
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
HSMN NewsFeed,
11 Jan 2010:
Biopharmaceuticals, Generics, FDA, Litigation
[Mylan, Cephalon, Armodafinil, Nuvigil]
|
Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
HSMN NewsFeed,
8 Jan 2010:
Biopharmaceuticals, Personnel
[Cephalon]
|
Sopherion Therapeutics Receives FDA Fast Track Designation for Myocet in Metastatic Breast Cancer
HSMN NewsFeed,
7 Jan 2010:
Biopharmaceuticals, Oncology, FDA
[Sopherion Therapeutics, Myocet, doxorubicin, breast cancer]
|
Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
HSMN NewsFeed,
18 Dec 2009:
Biopharmaceuticals, Regulatory
[Ligand Pharmaceuticals, GlaxoSmithKline, Revolade, eltrombopag, Promacta]
|
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
HSMN NewsFeed,
17 Dec 2009:
Biopharmaceuticals, Personnel
[AMAG Pharmaceuticals, Feraheme, ferumoxytol]
|
Dennis Winger Joins Nektar Therapeutics' Board of Directors
HSMN NewsFeed,
14 Dec 2009:
Biopharmaceuticals, Personnel
[Nektar Therapeutics]
|
Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
HSMN NewsFeed,
2 Dec 2009:
Biopharmaceuticals, Generics, Litigation, FDA
[Cephalon, Teva Pharmaceutical, NUVIGIL, armodafinil]
|
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
HSMN NewsFeed,
5 Nov 2009:
Biopharmaceuticals, Oncology
[Cephalon, TREANDA, bendamustine, non-Hodgkin's lymphoma]
|
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
HSMN NewsFeed,
27 Oct 2009:
Biopharmaceuticals, Personnel
[Cephalon]
|
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
HSMN NewsFeed,
27 Oct 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Ligand Pharmaceuticals, Metabasis]
|
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
HSMN NewsFeed,
26 Oct 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Cephalon, BioAssets Development Corporation, etanercept]
|
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
HSMN NewsFeed,
24 Sep 2009:
Biopharmaceuticals, FDA
[Cephalon, NUVIGIL, armodafinil]
|
Accuray Announces Additions to Board of Directors
HSMN NewsFeed,
15 Sep 2009:
Devices, Oncology, Personnel
[Accuray, CyberKnife, radiosurgery, radiotherapy]
|
Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
HSMN NewsFeed,
31 Jul 2009:
Biopharmaceuticals, Oncology, Personnel
[Cephalon]
|
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
HSMN NewsFeed,
19 Jun 2009:
Biopharmaceuticals, Oncology
[Cephalon, lestaurtinib, acute myelogenous leukemia]
|
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
HSMN NewsFeed,
8 Jun 2009:
Biopharmaceuticals, Personnel
[ViroPharma]
|
Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy
HSMN NewsFeed,
1 Jun 2009:
Biopharmaceuticals
[Cephalon, NUVIGIL, armodafinil, sleep apnea, narcolepsy]
|
Clarient Launches New Breast Cancer Test
HSMN NewsFeed,
5 May 2009:
Diagnostics, Oncology
[Clarient, Clarient Insight Dx, Breast Cancer Profile]
|
Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
HSMN NewsFeed,
27 Apr 2009:
Biopharmaceuticals, Regulatory
[Ligand Pharmaceuticals, Wyeth, CONBRIZA, bazedoxifene, osteoporosis]
|
FABLYN Approved in Europe for the Treatment of Osteoporosis
HSMN NewsFeed,
24 Mar 2009:
Biopharmaceuticals, Regulatory
[Ligand Pharmaceuticals, Pfizer, FABLYN, lasofoxifene, osteoporosis]
|
Pfizer's Oncology Business Unit Appoints Senior Executive to Head U.S. Region
HSMN NewsFeed,
23 Mar 2009:
Biopharmaceuticals, Oncology, Personnel
[Pfizer]
|
Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer
HSMN NewsFeed,
18 Mar 2009:
Biopharmaceuticals, Oncology
[Sopherion Therapeutics, nonpegylated liposomal doxorubicin, doxorubicin, Myocet]
|
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
HSMN NewsFeed,
17 Mar 2009:
Biopharmaceuticals
[Cephalon, NUVIGIL, armodafinil, bipolar disorder, depression]
|
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
HSMN NewsFeed,
27 Feb 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Cephalon, Arana Therapeutics]
|
Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs
HSMN NewsFeed,
24 Feb 2009:
Biopharmaceuticals, Personnel
[Sopherion Therapeutics]
|
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
HSMN NewsFeed,
4 Feb 2009:
Biopharmaceuticals, Drug Delivery, Personnel
[Cephalon, CIMA LABS]
|
Cephalon Signs Option Agreement to Acquire Ception Therapeutics
HSMN NewsFeed,
13 Jan 2009:
Biopharmaceuticals
[Cephalon, Ception Therapeutics, reslizumab]
|
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
HSMN NewsFeed,
9 Jan 2009:
Biopharmaceuticals, Licensing
[Azur Pharma, UCB, Niravam, Parcopa, Kemstro, Fluxid]
|
Impax Confirms Patent Challenge Relating to Amrix (R) Extended-Release Capsules, 15mg and 30mg
HSMN NewsFeed,
8 Jan 2009:
Biopharmaceuticals, Generics, Litigation
[IMPAX Laboratories, cyclobenzaprine, Amrix]
|
Adolor Corporation Announces Management Appointments
HSMN NewsFeed,
7 Jan 2009:
Biopharmaceuticals, Personnel
[Adolor]
|
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
HSMN NewsFeed,
26 Nov 2008:
Biopharmaceuticals, Generics, Litigation
[Cephalon, Eurand, Mylan Pharmaceuticals, Barr Pharmaceuticals, cyclobenzaprine]
|
David R. King Joins Diasome Pharmaceuticals as Chairman of the Board
HSMN NewsFeed,
24 Nov 2008:
Biopharmaceuticals, Endocrinology, Drug Delivery, Personnel
[Diasome Pharmaceuticals]
|
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
HSMN NewsFeed,
3 Nov 2008:
Biopharmaceuticals, Oncology, FDA
[Cephalon, TREANDA, bendamustine, Indolent NHL, non-Hodgkin's lymphoma]
|
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
HSMN NewsFeed,
21 Oct 2008:
Biopharmaceuticals, Generics, FDA
[Cephalon, Eurand , Mylan , AMRIX, Cyclobenzaprine]
|
Adolor Appoints John M. Limongelli as Senior Vice President, General Counsel and Secretary
HSMN NewsFeed,
10 Sep 2008:
Biopharmaceuticals, Personnel
[Adolor]
|
Pharmacopeia Announces Further Reductions to Workforce
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals
[Pharmacopeia]
|
Alkermes Announces Approval of VIVITROL(R) for the Treatment of Alcohol Dependence in Russia
HSMN NewsFeed,
4 Aug 2008:
Biopharmaceuticals, Regulatory
[Alkermes, Cilag GmbH, VIVITROL, naltrexone, alcohol dependence]
|
Longitude Capital Closes $325 Million Life Sciences Fund
HSMN NewsFeed,
8 Jul 2008:
Venture Capital
[Longitude Capital]
|
Industry Veteran David R. King Joins Quaker BioVentures
HSMN NewsFeed,
12 Jun 2008:
Venture Capital
[Quaker BioVentures]
|
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
HSMN NewsFeed,
3 Jun 2008:
Biopharmaceuticals, Litigation, Generics
[Cephalon, CIMA LABS, Watson Pharmaceuticals, FENTORA, fentanyl buccal tablet]
|
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
HSMN NewsFeed,
29 May 2008:
Biopharmaceuticals, Personnel
[Alexza Pharmaceuticals]
|
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
HSMN NewsFeed,
6 May 2008:
Biopharmaceuticals, FDA
[Cephalon, FENTORA, fentanyl buccal tablet]
|
Cephalon Notified of Generic Fentanyl Buccal Tablet Filing
HSMN NewsFeed,
24 Apr 2008:
Biopharmaceuticals, Generics
[Cephalon, Watson Laboratories, FENTORA, fentanyl buccal tablet]
|
NCCN Updates Non-Hodgkin's Lymphoma Guidelines
HSMN NewsFeed,
22 Apr 2008:
Biopharmaceuticals, Oncology
[NCCN, Non-Hodgkins Lymphoma, bendamustine, rituximab, Rituxan, Genentech]
|
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
HSMN NewsFeed,
14 Apr 2008:
Biopharmaceuticals, Oncology, Regulatory
[Cephalon, EFFENTORA, fentanyl, buccal tablet]
|
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
HSMN NewsFeed,
10 Apr 2008:
Biopharmaceuticals, Personnel
[Pharmacopeia]
|
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
HSMN NewsFeed,
3 Apr 2008:
Biopharmaceuticals, Personnel
[Alba Therapeutics]
|
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals, Drug Delivery, Licensing
[Acusphere, Cephalon, Hydrophobic Drug Delivery, AI-850, paclitaxel]
|
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
HSMN NewsFeed,
20 Mar 2008:
Biopharmaceuticals, Oncology, FDA
[Cephalon, TREANDA, bendamustine, chronic lymphocytic leukemia]
|
Alkermes Announces Restructuring
HSMN NewsFeed,
19 Mar 2008:
Biopharmaceuticals
[Alkermes, Eli Lilly, AIR Insulin]
|
Alkermes Receives Notice from Eli Lilly Terminating Inhaled Insulin Program
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, Drug Delivery, Endocrinology
[Alkermes, Eli Lilly, AIR Insulin, Inhaled Insulin, diabetes]
|
Alkermes Provides Update on Inhaled Insulin Program
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, Drug Delivery, Endocrinology
[Alkermes, Eli Lilly, AIR Insulin, Inhaled Insulin, diabetes]
|
inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
HSMN NewsFeed,
6 Mar 2008:
Biopharmaceuticals
[inVentiv Health, Cephalon, Amrix]
|
Pharmacopeia Announces Management Team Changes
HSMN NewsFeed,
28 Feb 2008:
Biopharmaceuticals, Personnel
[Pharmacopeia]
|
FDA Accepts TREANDA(R) New Drug Application for the Treatment of Relapsed Indolent Non-Hodgkin's Lymphoma
HSMN NewsFeed,
19 Feb 2008:
Biopharmaceuticals, Oncology
[Cephalon, TREANDA, bendamustine, B-cell, non-Hodgkin's lymphoma]
|
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
HSMN NewsFeed,
25 Jan 2008:
Biopharmaceuticals
[Cephalon, FENTORA, fentanyl buccal tablet]
|
Cephalon's EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
HSMN NewsFeed,
24 Jan 2008:
Biopharmaceuticals, Drug Delivery, Regulatory
[Cephalon, EFFENTORA, fentanyl buccal tablet]
|
Alkermes Announces Agreement for the Commercialization of VIVITROL in Russia/CIS
HSMN NewsFeed,
7 Jan 2008:
Biopharmaceuticals
[Alkermes, Cilag GmbH International, Johnson & Johnson, VIVITROL, naltrexone]
|
Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
HSMN NewsFeed,
31 Dec 2007:
Biopharmaceuticals, Oncology, FDA
[Cephalon, TREANDA, bendamustine, non-Hodgkin's lymphoma]
|
Ambit Biosciences Raises Over $49 Million in Series D Financing
HSMN NewsFeed,
14 Nov 2007:
Biopharmaceuticals, Venture Capital
[Ambit Biosciences]
|
Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals, Personnel
[Cephalon]
|
Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkin's Lymphoma
HSMN NewsFeed,
23 Oct 2007:
Biopharmaceuticals, Oncology
[Cephalon, TREANDA, bendamustine, non-Hodgkin's lymphoma]
|
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
HSMN NewsFeed,
15 Oct 2007:
Biopharmaceuticals, Licensing
[Pharmacopeia, Bristol-Myers Squibb, selective androgen receptor modulator]
|
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed,
4 Oct 2007:
Biopharmaceuticals, Personnel
[Hyperion Therapeutics]
|
Nitec Pharma Expands Senior Management Team
HSMN NewsFeed,
4 Oct 2007:
Biopharmaceuticals, Personnel
[Nitec Pharma]
|
Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
HSMN NewsFeed,
3 Oct 2007:
Biopharmaceuticals, Personnel
[Prism Pharmaceuticals]
|
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
HSMN NewsFeed,
21 Sep 2007:
Biopharmaceuticals, Oncology
[Cephalon, TREANDA, bendamustine, chronic lymphocytic leukemia]
|
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
HSMN NewsFeed,
13 Sep 2007:
Biopharmaceuticals, Drug Delivery
[Cephalon, FENTORA, fentanyl buccal tablet]
|
Pharmacopeia Announces Senior Additions to Management Team
HSMN NewsFeed,
11 Sep 2007:
Biopharmaceuticals, Personnel
[Pharmacopeia]
|
NeurogesX Appoints New Director to the Board
HSMN NewsFeed,
5 Sep 2007:
Biopharmaceuticals, Personnel
[NeurogesX]
|
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
HSMN NewsFeed,
29 Aug 2007:
Biopharmaceuticals, Oncology, FDA
[Cephalon, orphan drug designation, TREANDA, bendamustine, CLL]
|
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Acquisitions
[Cephalon, ECR Pharmaceuticals, AMRIX, cyclobenzaprine]
|
AEterna Zentaris completes management team with the appointment of Chief Medical Officer
HSMN NewsFeed,
16 Aug 2007:
Biopharmaceuticals, Personnel
[AETERNA ZENTARIS]
|
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
HSMN NewsFeed,
16 Aug 2007:
Biopharmaceuticals, Drug Delivery
[Cephalon, FENTORA, fentanyl buccal tablet]
|
Jan H. Egberts, M.D. Resigns as President and CEO of NovaDel Pharma
HSMN NewsFeed,
25 Jul 2007:
Biopharmaceuticals, Personnel
[NovaDel Pharma]
|
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
HSMN NewsFeed,
20 Jul 2007:
Biopharmaceuticals, Generics, FDA
[Caraco Pharmaceutical, Modafinil, Provigil, Cephalon]
|
Cephalon Announces Plans for New NDA Filing for TREANDA(R)
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Oncology, FDA
[Cephalon, TREANDA, bendamustine, chronic lymphocytic leukemia]
|
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
HSMN NewsFeed,
18 Jun 2007:
Biopharmaceuticals, FDA
[Cephalon, NUVIGIL, armodafinil]
|
Victory Pharma, Inc. Announces Dr. Shawn A. Scranton as Vice President of Scientific Operations
HSMN NewsFeed,
22 May 2007:
Biopharmaceuticals, Personnel
[Victory Pharma]
|
Tulip BioMed Appoints New President and Chief Operating Officer; Chief Financial Officer Adds Secretary and Treasurer Titles
HSMN NewsFeed,
9 May 2007:
Devices, Personnel
[Tulip BioMed]
|
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
HSMN NewsFeed,
1 May 2007:
Biopharmaceuticals, Drug Delivery
[Cephalon, FENTORA, fentanyl buccal tablet, fentanyl, neuropathic pain]
|
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
HSMN NewsFeed,
25 Apr 2007:
Biopharmaceuticals, Drug Delivery
[Alkermes, Indevus Pharmaceuticals, ALKS 27, trospium, COPD]
|
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
HSMN NewsFeed,
18 Apr 2007:
Biopharmaceuticals, Devices, Cardiology
[Vasogen, Grupo Ferrer, Celacade]
|
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
HSMN NewsFeed,
13 Apr 2007:
Biopharmaceuticals, FDA
[Janssen, Alkermes, RISPERDAL CONSTA , risperidone, schizophrenia]
|
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
HSMN NewsFeed,
30 Mar 2007:
Biopharmaceuticals, FDA
[Cephalon, NUVIGIL, armodafinil]
|
Cephalon Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
HSMN NewsFeed,
26 Mar 2007:
Biopharmaceuticals, Regulatory
[Cephalon, fentanyl, effervescent buccal tablet, FENTORA]
|
Alkermes Announces Senior Management Succession Plan
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Personnel
[Alkermes]
|
NovaDel Pharma Announces the Completion of Its Executive Team
HSMN NewsFeed,
26 Feb 2007:
Biopharmaceuticals, Personnel
[NovaDel Pharma]
|
Lundbeck USA Signs Lease Agreement to Establish U.S. Headquarters in King of Prussia, Pennsylvania
HSMN NewsFeed,
8 Feb 2007:
Biopharmaceuticals
[Lundbeck USA, Lundbeck]
|
Cephalon Comments on Study of its Leukemia Treatment Led by National Cancer Institute Cooperative Group
HSMN NewsFeed,
24 Jan 2007:
Biopharmaceuticals, Oncology
[Cephalon, TRISENOX, arsenic trioxide, acute promyelocytic leukemia]
|
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
HSMN NewsFeed,
10 Jan 2007:
Biopharmaceuticals, Neurology, Licensing, Distribution
[Insmed, Cephalon, IPLEX , Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease]
|
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
HSMN NewsFeed,
9 Jan 2007:
Biopharmaceuticals, Drug Delivery
[Cephalon, FENTORA, fentanyl buccal tablet]
|
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Drug Delivery
[Cephalon, FENTORA, fentanyl buccal tablet, breakthrough pain]
|
Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Endocrinology, Drug Delivery, Licensing
[Alkermes, Eli Lilly, AIR Insulin, Inhaled Insulin, diabetes]
|
Ambit Biosciences Appoints Wendell Wierenga, Ph.D., as Executive Vice President of Research & Development
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Personnel
[Ambit Biosciences]
|
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
HSMN NewsFeed,
4 Jan 2007:
Biopharmaceuticals
[Alkermes, Indevus Pharmaceuticals, trospium chloride, COPD]
|
Alkermes Announces Submission of New Drug Application for RISPERDAL(R) CONSTA(R) in Japan
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals, Regulatory
[Alkermes, Janssen-Cilag, Janssen Pharmaceutica , RISPERDAL, risperidone]
|
Ambit Biosciences Announces Establishment of Clinical Oncology Advisory Board
HSMN NewsFeed,
13 Dec 2006:
Biopharmaceuticals, Oncology, Personnel
[Ambit Biosciences]
|
Beijing Med-Pharm Corporation Enters Into an Agreement to Develop and Register Products for Cephalon, Inc. in China
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals
[Beijing Med-Pharm, Cephalon, FENTORA, fentanyl buccal tablet]
|
Cephalon Provides Update Related to Final NUVIGIL(TM) Labeling
HSMN NewsFeed,
7 Dec 2006:
Biopharmaceuticals, FDA
[Cephalon, SPARLON, modafinil, NUVIGIL, armodafinil]
|
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
HSMN NewsFeed,
5 Dec 2006:
Biopharmaceuticals, Personnel
[Ambit Biosciences]
|
Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA LABS
HSMN NewsFeed,
4 Dec 2006:
Biopharmaceuticals, Personnel
[Cephalon, CIMA LABS]
|
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
HSMN NewsFeed,
6 Nov 2006:
Biopharmaceuticals, Personnel
[Pharmacopeia]
|
Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
HSMN NewsFeed,
11 Oct 2006:
Biopharmaceuticals, Drug Delivery
[Cephalon, FENTORA, fentanyl buccal tablet, fentanyl]
|
Diatos Strengthens Management Team with the Appointment of New Chief Medical Officer and New Chief Sales & Marketing Officer
HSMN NewsFeed,
9 Oct 2006:
Biopharmaceuticals, Personnel
[Diatos SA]
|
Barr Launches Generic ACTIQ(R) Cancer Pain Management Product
HSMN NewsFeed,
27 Sep 2006:
Biopharmaceuticals, Generics, Drug Delivery
[Barr Pharmaceuticals, Cephalon, ACTIQ, fentanyl,]
|
Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal tablet) for the Management of Breakthrough Pain in Patients with Cancer
HSMN NewsFeed,
25 Sep 2006:
Biopharmaceuticals, Oncology, Drug Delivery, FDA
[Cephalon, FENTORA, fentanyl, buccal tablet]
|
NuPathe Closes $15 Million Financing
HSMN NewsFeed,
13 Sep 2006:
Biopharmaceuticals, Venture Capital
[NuPathe]
|
Merge Healthcare Announces New President and CEO and Additional Members to Board of Directors
HSMN NewsFeed,
6 Sep 2006:
Devices, Personnel
[Merge Healthcare]
|
Sapphire Therapeutics, Inc. Expands Drug Development Team
HSMN NewsFeed,
25 Aug 2006:
Biopharmaceuticals, Personnel
[Sapphire Therapeutics]
|
Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice President Worldwide Medical and Regulatory Operations
HSMN NewsFeed,
25 Aug 2006:
Biopharmaceuticals, Personnel
[ Cephalon]
|
Cephalon Receives Non-Approvable Letter on SPARLON(TM)
HSMN NewsFeed,
9 Aug 2006:
Biopharmaceuticals, FDA
[Cephalon, SPARLON, modafinil]
|
Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl buccal tablet) for Management of Breakthrough Pain in Patients with Cancer
HSMN NewsFeed,
29 Jun 2006:
Biopharmaceuticals, Drug Delivery, FDA
[Cephalon, FENTORA, fentanyl, buccal tablet]
|
Cephalon Announces Results from GABITRIL(R) Clinical Program in Generalized Anxiety Disorder
HSMN NewsFeed,
26 Jun 2006:
Biopharmaceuticals
[Cephalon, GABITRIL, tiagabine, generalized anxiety disorder]
|
Celator Pharmaceuticals Appoints Industry Veteran Felix Botelho as Head of Commercial Development
HSMN NewsFeed,
26 Jun 2006:
Biopharmaceuticals, Personnel
[Celator Pharmaceuticals]
|
Cephalon and Takeda Announce Agreement to Co-Promote PROVIGIL(R) in the United States
HSMN NewsFeed,
12 Jun 2006:
Biopharmaceuticals
[Cephalon, Takeda Pharmaceuticals, PROVIGIL, modafinil]
|
Cephalon's Fentanyl Effervescent Buccal Tablet Reduces Intensity of Breakthrough Pain in Cancer Patients
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals, Drug Delivery
[Cephalon, fentanyl, buccal tablet, FEBT]
|
Othera Pharmaceuticals Elects Katherine Crothall and Bruce Peacock to Board
HSMN NewsFeed,
3 May 2006:
Biopharmaceuticals, Personnel
[Othera Pharmaceuticals]
|
Cephalon Receives Approvable Letter for NUVIGIL(TM) (armodafinil)
HSMN NewsFeed,
1 May 2006:
Biopharmaceuticals, FDA
[Cephalon, NUVIGIL, armodafinil]
|
Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)
HSMN NewsFeed,
24 Apr 2006:
Biopharmaceuticals, FDA
[Cephalon, SPARLON, modafinil, ADHD]
|
Alkermes and Cephalon Receive FDA Approval of Vivitrol(TM) for the Treatment of Alcohol Dependence
HSMN NewsFeed,
13 Apr 2006:
Biopharmaceuticals, FDA
[Alkermes, Cephalon, VIVITROL, naltrexone, Alcohol dependence]
|
Cephalon Oncology Compound Lestaurtinib (CEP-701) Granted Orphan Drug Designation for Acute Myeloid Leukemia
HSMN NewsFeed,
4 Apr 2006:
Biopharmaceuticals, FDA, Oncology
[Cephalon, orphan drug designation, lestaurtinib, CEP-701, acute myeloid leukemia]
|
Mona Haynes Joins Acusphere in Newly Created Position of Vice President, Marketing and Sales
HSMN NewsFeed,
29 Mar 2006:
Biopharmaceuticals, Personnel
[Acusphere]
|
Cephalon Granted Six Months of Pediatric Exclusivity for PROVIGIL(R)
HSMN NewsFeed,
28 Mar 2006:
Biopharmaceuticals, FDA
[Cephalon, PROVIGIL, modafinil]
|
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Distribution, Licensing
[IDM Pharma, Medison Pharma, Junovan]
|
IDM and GENESIS Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in South East Europe
HSMN NewsFeed,
21 Feb 2006:
Biopharmaceuticals, Licensing
[IDM Pharma, GENESIS Pharma, Junovan]
|
Alkermes Announces Submission of Complete Response to FDA for VIVITROL(TM) New Drug Application
HSMN NewsFeed,
17 Feb 2006:
Biopharmaceuticals, FDA
[Alkermes, VIVITROL, naltrexone]
|
Barr Announces Agreements with Cephalon, Inc. Regarding Settlement of ACTIQ(R) and PROVIGIL(R) Patent Litigations
HSMN NewsFeed,
1 Feb 2006:
Biopharmaceuticals, Generics, Litigation
[Barr Pharmaceuticals, Cephalon, PROVIGIL, modafinil, ACTIQ]
|
Cephalon, Inc. Announces Agreements With Barr Laboratories, Inc. Regarding Settlement of PROVIGIL(R) and ACTIQ(R) Patent Litigations
HSMN NewsFeed,
1 Feb 2006:
Biopharmaceuticals, Generics, Litigation
[Cephalon, Barr Laboratories, PROVIGIL, modafinil, ACTIQ]
|
Cephalon, Inc. Provides Update on Regulatory Status of NUVIGIL(TM)
HSMN NewsFeed,
1 Feb 2006:
Biopharmaceuticals, FDA
[Cephalon, NUVIGIL, armodafinil]
|
Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)
HSMN NewsFeed,
25 Jan 2006:
Biopharmaceuticals
[Cephalon, SPARLON, modafinil, ADHD]
|
Mylan Technologies Inc. Signs Two Strategic Agreements With Cephalon to Utilize MTI's Advanced Transdermal Technology
HSMN NewsFeed,
11 Jan 2006:
Biopharmaceuticals
[Mylan Laboratories, Mylan Technologies, Cephalon]
|
Cephalon, Inc. Announces Agreement with Mylan Pharmaceuticals Inc. Regarding Settlement of PROVIGIL(R) Patent Litigation
HSMN NewsFeed,
10 Jan 2006:
Biopharmaceuticals, Generics, Litigation
[Cephalon, Mylan Pharmaceuticals, PROVIGIL, modafinil]
|
|
|
 |
Additional items found:
The Network Archive contains
81 additional items
matching: Cephalon
<< Members - click the icon at left to display. |
|
| |
|
|
|
|
Public
Feeds 
Full text >>